<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100119003106N42</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-07-05</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Evaluation of therapeutic effect of topical semi-solid product containing sucralfate, zinc oxide, aloe Vera gel and peppermint essential oil and zinc oxide ointment in natural base containing Ghee oil and comparison with standard treatment containing zinc oxide in normal base in the process of healing and treatment of diaper rash</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of therapeutic effect of topical semi-solid product containing sucralfate, zinc oxide, aloe Vera gel and peppermint essential oil and zinc oxide ointment in natural base containing Ghee oil and comparison with standard treatment containing zinc oxide in normal base in the process of healing and treatment of diaper rash: a pilot study And parallel</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/62492</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Zu diesem Zweck werden 60 Umschläge (20 mit der ersten Arzneimittelkarte und 20 mit der zweiten Arzneimittelkarte und 20 mit der Placebokarte) vorbereitet. Umschläge sind mit Nummern von 1 bis 40 gekennzeichnet. Die Patienten werden nach dem Öffnen des versiegelten Umschlags einer von zwei Medikamenten- bzw. Placebogruppen, Nummer 1 bis 40, zugeordnet, Blinding description: The patients, physicians, researcher and data collector (student) don’t know about who was receiving the placebo  and who receiving a placebo. 
The informed consent was obtained from patients and they were informed that they could leave the trial at any time.
The coding of the medicine boxes was done by a third party who was not involved in the study and at the end of the study, decryption took place.
All tubes of the drug are the same in terms of design and color, while the cover of the prescribed tubes is coded.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Diaper rash.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The first intervention group of patients receiving medicine containing zinc oxide and sucralfate and aloe vera gel and peppermint essential oil (made by Pharm.D. students in pharmaceuticals lab in Azad university)  for 7 days after each diaper change. Intervention 2: Intervention group:  the second intervention group received animal oil made by researchers of the Faculty of Pharmacy of Tehran Azad University of Medical Sciences for 7 days after each diaper change. Intervention 3: Control group: Patients take placebo medicine made by researchers of the Faculty of Pharmacy of Tehran Azad University of Medical Sciences, which contains zinc oxide and the usual base for 7 days after each diaper change.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the data potentially can be shared after being unidentifiable.

When:
Just after the articles publication.

To whom:
For all investigators.

Conditions:
The person requesting the data should be a relevant expert in this field - All statistical analyzes performed can be provided - Information can be used by mentioning the name of the research and referencing the site to the research - Requirements: Mentioning the name of the research and codes Relevant research and all the required information as well as the name of the researcher and communication channels in case of receiving the required information.

Where to obtain:
Application can refer to the Department of Clinical Pharmacy, Faculty of pharmacy, Tehran Medical Science, Islamic Azad University, Dr. Hashemian or contact the researcher by sending email to shabanelahe@gmail.com or calling 09210907926.

How to obtain:
Application can apply for research information by visiting the department or by contacting the e-mail address and telephone number as well as providing information on academic studies and the purpose of requesting the information. Applicant must commit themselves to mention the source. If the request is sent six months after the publication of research information the researcher will send the data to the requesting party by email within a week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Elaheh Shaban</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 99, Yasman Alley, Yakhchal street, Gholhak, Dr. Shariati street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>193956466</zip>
        <telephone>+98 21 2264 0051</telephone>
        <email>shabanelahe@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Farshad Hashemian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 99, Yasman Alley, Yakhchal street, Gholhak, Dr. Shariati street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>193956466</zip>
        <telephone>+98 21 2264 0599</telephone>
        <email>hashemian.f@iaups.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Doctor's diagnosis of having diaper rash
Age between one day to 24 months
Parental consent to cooperate and use medication</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>2 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Existence of deep ulcers, infection or fungal lesions, need for treatment with other drugs such as corticosteroids and antibiotics.
Bloody stools
Fever
Underlying diseases
History of allergies to topical products containing zinc, aloe Vera or products contains essential oil of mint, and cow's milk protein</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L22</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Diaper dermatitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The first intervention group of patients receiving medicine containing zinc oxide and sucralfate and aloe vera gel and peppermint essential oil (made by Pharm.D. students in pharmaceuticals lab in Azad university)  for 7 days after each diaper change.</i_keyword>
      <i_keyword>Intervention group:  the second intervention group received animal oil made by researchers of the Faculty of Pharmacy of Tehran Azad University of Medical Sciences for 7 days after each diaper change</i_keyword>
      <i_keyword>Control group: Patients take placebo medicine made by researchers of the Faculty of Pharmacy of Tehran Azad University of Medical Sciences, which contains zinc oxide and the usual base for 7 days after each diaper change.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Diaper Dermatitis Grading Scale. Timepoint: The beginning of the study (before the intervention) and the second, fourth, sixth days and after the intervention. Method of measurement: Diaper Dermatitis Grading Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-02-21</approval_date>
        <contact_name>Ethics committee of Islamic Azad University, Pharmaceutical Sciences Branch</contact_name>
        <contact_address>Islamic Azad University, Pharmaceutical Sciences Branch, Dr. Shariati Ave., Qolhak., Yakhchal St., Yasaman Ave., Tehran Town Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
